1. با استفاده از خون Anti-RhE ایجاد رده سلولی لنفوبلاستوئید تولیدکننده بیماران تالاسمی آلوایمیون.
- Author
-
مهدی شکفت, سعیده میلاني, زهره شریفي, and آرزو اودی
- Subjects
- *
HEMAGGLUTINATION tests , *B cells , *MONONUCLEAR leukocytes , *IMMUNOGLOBULINS , *TIME , *CYCLOSPORINE , *EPSTEIN-Barr virus , *ENZYME-linked immunosorbent assay , *THALASSEMIA , *CELL lines - Abstract
Background and Objectives One of the applications of Epstein-Barr virus in research is the immortalization of B lymphocytes and the creation of the lymphoblastoid cell line. People with thalassemia usually need blood transfusion, the main complication of which is alloimmunization. Antibody against RhE antigen causes hemolytic reactions. The aim of this study is to create a lymphoblastoid cell line that produces anti-E using peripheral blood mononuclear cells of alloimmune thalassemia patients against E antigen when exposed to Epstein Bar Virus (EBV). Materials and Methods In an experimental study, the mononuclear cells of 3 patients were isolated by Ficol and mixed with EBV. The transformed cells were cultured in RPMI medium containing cyclosporine. After 2-3 weeks, the formation of clones in the wells was checked and the hemagglutination test was performed for the wells containing the growing cells; the total amount of antibody in positive wells was measured by ELISA method. Results Exposure of mononuclear cells of patients with EBV led to cell transformation and creation of clones in some wells. The results of hemagglutination and ELISA methods showed that the clones were able to produce antibodies against the RhE antigen. Conclusions Anti-E antibody-producing lymphoblastoid cell line can be created by using sensitized cells of thalassemia patients against RhE antigen and its immortalization by EBV transformation method. [ABSTRACT FROM AUTHOR]
- Published
- 2022